A detailed history of Nisa Investment Advisors, LLC transactions in Bluebird Bio, Inc. stock. As of the latest transaction made, Nisa Investment Advisors, LLC holds 1,469 shares of BLUE stock, worth $734. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,469
Previous 1,048 40.17%
Holding current value
$734
Previous $1,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 19, 2024

BUY
$0.85 - $1.26 $357 - $530
421 Added 40.17%
1,469 $1,000
Q1 2024

May 01, 2024

SELL
$0.91 - $1.75 $89 - $171
-98 Reduced 8.55%
1,048 $1,000
Q4 2023

Jan 25, 2024

BUY
$1.32 - $4.83 $130 - $478
99 Added 9.46%
1,146 $1,000
Q3 2023

Nov 02, 2023

BUY
$3.02 - $4.05 $21 - $28
7 Added 0.67%
1,047 $3,000
Q1 2023

May 02, 2023

SELL
$3.14 - $8.22 $175 - $460
-56 Reduced 5.11%
1,040 $3,000
Q3 2022

Nov 07, 2022

BUY
$3.75 - $7.39 $322 - $635
86 Added 8.51%
1,096 $7,000
Q3 2021

Oct 18, 2021

SELL
$11.24 - $21.0 $20,232 - $37,800
-1,800 Reduced 64.06%
1,010 $19,000
Q2 2021

Aug 06, 2021

SELL
$18.04 - $22.09 $28,683 - $35,123
-1,590 Reduced 36.14%
2,810 $90,000
Q1 2021

Apr 26, 2021

BUY
$16.59 - $33.89 $1,659 - $3,389
100 Added 2.33%
4,400 $133,000
Q4 2020

Jan 25, 2021

SELL
$27.5 - $37.92 $70,290 - $96,923
-2,556 Reduced 37.28%
4,300 $186,000
Q3 2020

Oct 20, 2020

BUY
$34.44 - $43.75 $43,979 - $55,868
1,277 Added 22.89%
6,856 $370,000
Q2 2020

Jul 27, 2020

BUY
$27.12 - $45.97 $100,859 - $170,962
3,719 Added 199.95%
5,579 $341,000
Q1 2020

Apr 17, 2020

BUY
$26.16 - $63.5 $18,835 - $45,720
720 Added 63.16%
1,860 $85,000
Q4 2019

Jan 17, 2020

BUY
$46.96 - $61.67 $3,756 - $4,933
80 Added 7.55%
1,140 $100,000
Q3 2019

Oct 17, 2019

BUY
$59.47 - $93.1 $60,064 - $94,031
1,010 Added 2020.0%
1,060 $97,000
Q2 2019

Jul 12, 2019

BUY
$75.84 - $105.21 $3,033 - $4,208
40 Added 400.0%
50 $6,000
Q1 2019

Apr 17, 2019

SELL
$64.44 - $104.11 $161,228 - $260,483
-2,502 Reduced 99.6%
10 $2,000
Q3 2018

Oct 16, 2018

BUY
$88.86 - $117.49 $217,884 - $288,085
2,452 Added 4086.67%
2,512 $367,000
Q2 2018

Jul 19, 2018

SELL
$99.64 - $127.59 $15,942 - $20,414
-160 Reduced 72.73%
60 $9,000
Q1 2018

Apr 10, 2018

SELL
$105.8 - $150.94 $7,406 - $10,565
-70 Reduced 24.14%
220 $38,000
Q4 2017

Jan 12, 2018

BUY
$81.25 - $130.7 $2,437 - $3,920
30 Added 11.54%
290 $52,000
Q3 2017

Oct 13, 2017

BUY
$57.74 - $91.42 $15,012 - $23,769
260
260 $36,000

Others Institutions Holding BLUE

About bluebird bio, Inc.


  • Ticker BLUE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,121,800
  • Market Cap $38.6M
  • Description
  • bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...
More about BLUE
Track This Portfolio

Track Nisa Investment Advisors, LLC Portfolio

Follow Nisa Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nisa Investment Advisors, LLC with notifications on news.